Bandaram Pharma Pack
Ticker > Company >

Bandaram Pharma Pack share price

Bandaram Pharma Packtech Ltd.

BSE: 524602 SECTOR: Pharmaceuticals & Drugs  7.53 K   3   0

32.09
-0.55 (-1.69%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 34

Today's Low

₹ 31.3

52 Week High

₹ 63.14

52 Week Low

₹ 31

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 38.51 Cr.

Enterprise Value

₹ 38.49 Cr.

No. of Shares

1.2 Cr.

P/E

315.54

P/B

3.25

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  9.86

CASH

₹ 0.04 Cr.

DEBT

₹ 0.02 Cr.

Promoter Holding

75 %

EPS (TTM)

₹  0.1

Sales Growth

47.01%

ROE

1.68 %

ROCE

1.81%

Profit Growth

-37.12 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year47.01%
3 Year∞%
5 Year∞%

Profit Growth

1 Year-37.12%
3 Year82.33%
5 Year16.19%

ROE%

1 Year1.68%
3 Year1.8%
5 Year1.08%

ROCE %

1 Year1.81%
3 Year2.03%
5 Year1.22%

Debt/Equity

0.0014

Price to Cash Flow

-11.91

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 75.00 0.00
Mar 2025 75.00 0.00
Dec 2024 75.00 0.00
Sep 2024 75.00 0.00
Jun 2024 75.00 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 4.3875 Cr.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 67.2639 days.
  • Company has a healthy liquidity position with current ratio of 7.8536.
  • The company has a high promoter holding of 75%.

 Limitations

  • Company has a poor ROE of 1.79857325387084% over the past 3 years.
  • Company has a poor ROCE of 2.02706752007683% over the past 3 years
  • Company has contingent liabilities of 10.17 Cr.
  • Company has negative cash flow from operations of -3.2321.
  • The company has a low EBITDA margin of 0.7501% over the past 5 years.
  • The company is trading at a high PE of 315.54.
  • The company is trading at a high EV/EBITDA of 242.6301.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 2.72 3.17 2.63 3.71 0.76
Total Expenditure 2.97 2.83 2.58 3.75 1.03
Operating Profit -0.25 0.33 0.05 -0.04 -0.27
Other Income 0 0 0 0.09 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.25 0.33 0.05 0.06 -0.27
Tax 0 0 0.03 0.01 0
Profit After Tax -0.25 0.33 0.02 0.04 -0.27
Adjusted EPS (Rs) -0.21 0.28 0.01 0.04 -0.22

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 0 0 0 10.09 14.84
Total Expenditure 1.12 0.01 0.01 9.82 14.67
Operating Profit -1.12 -0.01 -0.01 0.27 0.17
Other Income 0 0 0 0 0.03
Interest 0.01 0 0 0 0
Depreciation 0.03 0.02 0 0 0.02
Exceptional Items 0 0 0 0 0
Profit Before Tax -1.16 -0.03 -0.01 0.27 0.18
Tax 0 0 0 0.07 0.05
Net Profit -1.16 -0.03 -0.01 0.2 0.13
Adjusted EPS (Rs.) -1.77 -0.05 -0.01 0.24 0.11

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 2.28 2.28 3 3 12
Total Reserves -4.06 -4.6 -0.01 0.07 0.2
Borrowings 1.2 1.45 0 4.41 0.02
Other N/C liabilities 0.97 0.97 0 0 0
Current liabilities 0.95 1.16 0.01 0.79 1.21
Total Liabilities 1.34 1.26 3 8.27 13.43
Assets
Net Block 0.17 0.11 0 0.02 0.01
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 2.51 3.91
Loans & Advances 0.39 0.39 0 0 0.01
Other N/C Assets 0 0 0 0 0
Current Assets 0.78 0.77 3 5.74 9.51
Total Assets 1.34 1.26 3 8.27 13.43
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -1.16 -0.03 -0.01 0.27 0.17
Adjustment 0.03 0.02 0 0 0.02
Changes in Assets & Liabilities 0.15 0.01 2.93 -4.14 -3.38
Tax Paid 0 0 0 0 -0.04
Operating Cash Flow -0.98 0 2.91 -3.87 -3.23
Investing Cash Flow 0.42 0 -1.55 -2.53 -1.4
Financing Cash Flow 0 0 0.72 4.4 4.61
Net Cash Flow -0.56 0 2.08 -2 -0.02

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 75.00 75.00 75.00 75.00 75.00
b.deepak reddy 15.00 39.38 39.38 39.38 39.38
b.premsai reddy 15.00 15.00 15.00 15.00 15.00
b.sathyavathi 15.00 15.00 15.00 15.00 15.00
l. lalanthika 3.75 3.75 3.75 3.75 3.75
m. seetharama reddy 0.94 0.94 0.94 0.94 0.94
m. sukumari 0.94 0.94 0.94 0.94 0.94
b.munirathnam reddy 24.38 - - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 25.00 25.00 25.00 25.00 25.00
sanivarapu jhansi 6.54 6.54 6.54 6.54 6.54
sanivarapu navya reddy 3.52 3.45 3.45 3.45 3.12
sapnaa 2.50 2.50 - 2.45 2.45
sreedar reddy g 3.33 3.33 3.33 3.33 3.33
suresh kumar surana 1.36 1.31 - 1.21 1.15
sapnaa . - - 2.45 - -
suresh kumar surana . - - 1.27 - -

Annual Reports

Title Link
Title Link
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Bandaram Pharma Packtech informs about record date 11 Sep, 2:12 PM Bandaram Pharma Packtech informs about newspaper publication 18 Aug, 5:38 PM Bandaram Pharma Pack - Quaterly Results 14 Aug, 3:26 PM Bandaram Pharma Pack - Quaterly Results 14 Aug, 3:26 PM Bandaram Pharma Pack - Quaterly Results 14 Aug, 3:26 PM Bandaram Pharma Packtech informs about board meeting 10 Feb, 5:31 PM Bandaram Pharma Packtech informs about certificate 15 Jan, 1:02 PM Bandaram Pharma Packtech informs about disclosure 6 Dec, 12:33 PM Bandaram Pharma Packtech informs about disclosure 5 Dec, 5:18 PM Bandaram Pharma Packtech informs about disclosure 4 Dec, 5:16 PM Bandaram Pharma Packtech informs about compliance certificate 24 Oct, 4:59 PM Bandaram Pharma Pack - Quaterly Results 13 Aug, 4:18 PM Bandaram Pharma Pack - Quaterly Results 13 Aug, 4:18 PM Bandaram Pharma Packtech informs about certificate 10 Jul, 3:54 PM Bandaram Pharma Packtech informs about clarification 20 Mar, 2:32 PM Bandaram Pharma Pack - Quaterly Results 12 Feb, 5:09 PM Bandaram Pharma Pack - Quaterly Results 12 Feb, 5:09 PM Bandaram Pharma Pack - Quaterly Results 12 Feb, 5:09 PM Bandaram Pharma Packtech informs about disclosure 1 Feb, 5:23 PM Bandaram Pharma Packtech informs about postponement of board meeting 28 Oct, 3:37 PM Bandaram Pharma Packtech informs about newspaper clippings 14 Sep, 5:07 PM Bandaram Pharma Packtech informs about newspaper clippings 14 Aug, 2:24 PM Bandaram Pharma Packtech informs about outcome of right issue committee 23 Jun, 3:58 PM Bandaram Pharma Packtech informs about board meeting 6 May, 1:45 PM Bandaram Pharma Packtech informs about EGM notice 13 Feb, 4:45 PM Bandaram Pharma Packtech informs about board meeting 1 Feb, 12:11 PM Bandaram Pharma Packtech informs about board meeting 25 Jan, 11:41 AM Bandaram Pharma Pack - Quaterly Results 9 Nov, 6:18 PM Bandaram Pharma Pack - Quaterly Results 9 Nov, 6:18 PM Bandaram Pharma Packtech informs about board meeting 3 Nov, 10:01 AM Bandaram Pharma Pack - Quaterly Results 22 Jul, 5:43 PM Bandaram Pharma Pack - Quaterly Results 22 Jul, 5:43 PM Bandaram Pharma Pack - Quaterly Results 22 Jul, 5:43 PM Bandaram Pharma Packtech informs about board meeting 21 May, 10:23 AM Shiva Medicare informs about disclosure 4 Apr, 4:57 PM Shiva Medicare informs about disclosures 4 Apr, 2:45 PM Shiva Medicare informs about outcome of board meeting 10 Mar, 3:08 PM Shiva Medicare informs about updates 25 Feb, 10:28 AM

Bandaram Pharma Pack Stock Price Analysis and Quick Research Report. Is Bandaram Pharma Pack an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Bandaram Pharma Pack. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Bandaram Pharma Pack has a PE ratio of 329.301868239921 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Bandaram Pharma Pack has ROA of 1.1835% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Bandaram Pharma Pack has a Current ratio of 7.8536.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Bandaram Pharma Pack has a ROE of 1.681%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Bandaram Pharma Pack has a Debt to Equity ratio of 0.0014 which means that the company has low proportion of debt in its capital.

  • Sales growth: Bandaram Pharma Pack has reported revenue growth of 47.0106% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Bandaram Pharma Pack for the current financial year is 1.12540517955941%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Bandaram Pharma Pack is Rs 0.1 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Bandaram Pharma Pack is Rs 0.1017. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Bandaram Pharma Pack in Ticker for free. Also, one can get the intrinsic value of Bandaram Pharma Pack by using Valuation Calculators, which are available with a Finology ONE subscription. 

Bandaram Pharma Pack FAQs

Q1. What is Bandaram Pharma Pack share price today?
Ans: The current share price of Bandaram Pharma Pack is Rs 33.49.

Q2. What is the market capitalisation of Bandaram Pharma Pack?
Ans: Bandaram Pharma Pack has a market capitalisation of Rs 40.188 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Bandaram Pharma Pack?
Ans: The PE ratio of Bandaram Pharma Pack is 329.301868239921 and the P/B ratio of Bandaram Pharma Pack is 3.39627616420574, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Bandaram Pharma Pack share?
Ans: The 52-week high share price of Bandaram Pharma Pack is Rs 63.14, and the 52-week low share price of Bandaram Pharma Pack is Rs 31.

Q5. Does Bandaram Pharma Pack pay dividends?
Ans: Currently, Bandaram Pharma Pack does not pay dividends. Dividend yield of Bandaram Pharma Pack is around 0%.

Q6. What are the face value and book value of Bandaram Pharma Pack shares?
Ans: The face value of Bandaram Pharma Pack shares is Rs 10, while the book value per share of Bandaram Pharma Pack is around Rs 9.8608. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Bandaram Pharma Pack?
Ans: Bandaram Pharma Pack has a total debt of Rs 0.0175 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Bandaram Pharma Pack?
Ans: The ROE of Bandaram Pharma Pack is 1.681% and ROCE of Bandaram Pharma Pack is 1.8113%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Bandaram Pharma Pack a good buy for the long term?
Ans: The Bandaram Pharma Pack long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Bandaram Pharma Pack undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Bandaram Pharma Pack appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Bandaram Pharma Pack’s financials?
Ans: You can review Bandaram Pharma Pack’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Bandaram Pharma Pack
X